Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T13:36:32.546Z.
Calculation as of: 2026-10-06T13:36:32.546Z.
Quote observation: 2026-10-06T13:35:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a99f3f088f54f9f9c0225e5104dac3e52b54f392bb47ad8d1f9af79329b73e7d
EARNINGS YIELD
N/A
Market Cap
$4.33B
Earnings Yield
N/A
TTM Avg
6.68%
3Y Avg
4.79%
5Y Avg
4.79%
Market Cap
$4.47B
Earnings Yield
7.79%
TTM Avg
5.11%
3Y Avg
3.07%
5Y Avg
3.43%
Market Cap
$4.61B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.78B
Earnings Yield
1.05%
TTM Avg
0.64%
3Y Avg
0.64%
5Y Avg
0.64%
Market Cap
$4.88B
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | $4.36B | N/A | N/A | N/A | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.33B | N/A | 6.68% | 4.79% | 4.79% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.47B | 7.79% | 5.11% | 3.07% | 3.43% |
| LivaNova PLC (LIVN)vs › | $4.21B | 4.42% | 3.24% | 1.64% | 1.64% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.61B | N/A | N/A | N/A | N/A |
| ICU Medical, Inc. (ICUI)vs › | $4.06B | 0.73% | 0.70% | 0.70% | 1.21% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.77B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.78B | 1.05% | 0.64% | 0.64% | 0.64% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.88B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.93B | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
